FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1703283460> ?p ?o ?g. }

• W1703283460 abstract "Chronic migraine is a neurological condition with a large individual and socioeconomic burden of disease. The recently completed Phase III REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) clinical development program established the efficacy and safety of onabotulinumtoxinA as a prophylactic treatment for chronic migraine patients. However, clinical questions remain. A long-term evaluation study of onabotulinumtoxinA aims to address some of the remaining questions in the treatment of chronic migraine. The clinical rationale, study design, and treatment plan of this ongoing study are reviewed in this paper.The Chronic migraine OnabotulinuMtoxinA Prolonged Efficacy open Label (COMPEL) study will enroll approximately 500 adult patients with chronic migraine at international sites. Patients will be evaluated over 108 weeks, following a 4-week baseline period. Qualified subjects will receive 155 U of onabotulinumtoxinA every 12 weeks for 9 open-label cycles. The primary endpoint will be mean change from baseline in frequency of headache days at 108 weeks. Other endpoints will include additional assessments of the efficacy and safety of onabotulinumtoxinA and the effect of onabotulinumtoxinA on quality-of-life measures, disability, and health economic outcomes. The impact of onabotulinumtoxinA on common comorbidities (eg, sleep, anxiety, and fatigue) will also be assessed.Recruitment and enrollment are ongoing. Post-approval, open-label studies are often designed to more closely resemble clinical practice and provide an opportunity to continue the evaluation of the efficacy and safety of approved treatments. By creating a large database and analyzing a variety of outcome measures over an extended time frame, the COMPEL study will seek to contribute substantially to the existing knowledge of the chronic migraine population and the long-term management of this debilitating disorder.NCT01516892." @default.
• W1703283460 created "2016-06-24" @default.
• W1703283460 creator A5033781758 @default.
• W1703283460 creator A5042135918 @default.
• W1703283460 creator A5050252532 @default.
• W1703283460 creator A5059017023 @default.
• W1703283460 date "2015-07-03" @default.
• W1703283460 modified "2023-10-18" @default.
• W1703283460 title "Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine" @default.
• W1703283460 cites W1963580555 @default.
• W1703283460 cites W1967364781 @default.
• W1703283460 cites W1968884564 @default.
• W1703283460 cites W1974101169 @default.
• W1703283460 cites W1994481205 @default.
• W1703283460 cites W2000049450 @default.
• W1703283460 cites W2004109997 @default.
• W1703283460 cites W2007410119 @default.
• W1703283460 cites W2009222901 @default.
• W1703283460 cites W2014208168 @default.
• W1703283460 cites W2015197538 @default.
• W1703283460 cites W2016302974 @default.
• W1703283460 cites W2025026230 @default.
• W1703283460 cites W2038833296 @default.
• W1703283460 cites W2043705607 @default.
• W1703283460 cites W2046085057 @default.
• W1703283460 cites W204766049 @default.
• W1703283460 cites W2066289781 @default.
• W1703283460 cites W2070011903 @default.
• W1703283460 cites W2073003556 @default.
• W1703283460 cites W2084866959 @default.
• W1703283460 cites W2087897540 @default.
• W1703283460 cites W2091046463 @default.
• W1703283460 cites W2103575883 @default.
• W1703283460 cites W2110078996 @default.
• W1703283460 cites W2114242035 @default.
• W1703283460 cites W2115337076 @default.
• W1703283460 cites W2118912931 @default.
• W1703283460 cites W2122311626 @default.
• W1703283460 cites W2124620979 @default.
• W1703283460 cites W2127042724 @default.
• W1703283460 cites W2132322340 @default.
• W1703283460 cites W2132968602 @default.
• W1703283460 cites W2134001075 @default.
• W1703283460 cites W2142670324 @default.
• W1703283460 cites W2151487996 @default.
• W1703283460 cites W2167719770 @default.
• W1703283460 cites W2170860462 @default.
• W1703283460 cites W2769724041 @default.
• W1703283460 cites W4230120862 @default.
• W1703283460 doi "https://doi.org/10.1186/s12883-015-0353-x" @default.
• W1703283460 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4489131" @default.
• W1703283460 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26133547" @default.
• W1703283460 hasPublicationYear "2015" @default.
• W1703283460 type Work @default.
• W1703283460 sameAs 1703283460 @default.
• W1703283460 citedByCount "22" @default.
• W1703283460 countsByYear W17032834602015 @default.
• W1703283460 countsByYear W17032834602016 @default.
• W1703283460 countsByYear W17032834602017 @default.
• W1703283460 countsByYear W17032834602018 @default.
• W1703283460 countsByYear W17032834602019 @default.
• W1703283460 countsByYear W17032834602020 @default.
• W1703283460 countsByYear W17032834602021 @default.
• W1703283460 countsByYear W17032834602023 @default.
• W1703283460 crossrefType "journal-article" @default.
• W1703283460 hasAuthorship W1703283460A5033781758 @default.
• W1703283460 hasAuthorship W1703283460A5042135918 @default.
• W1703283460 hasAuthorship W1703283460A5050252532 @default.
• W1703283460 hasAuthorship W1703283460A5059017023 @default.
• W1703283460 hasBestOaLocation W17032834601 @default.
• W1703283460 hasConcept C118552586 @default.
• W1703283460 hasConcept C126322002 @default.
• W1703283460 hasConcept C12770488 @default.
• W1703283460 hasConcept C159110408 @default.
• W1703283460 hasConcept C16568411 @default.
• W1703283460 hasConcept C1862650 @default.
• W1703283460 hasConcept C197934379 @default.
• W1703283460 hasConcept C203092338 @default.
• W1703283460 hasConcept C2778375690 @default.
• W1703283460 hasConcept C2778541695 @default.
• W1703283460 hasConcept C2779951463 @default.
• W1703283460 hasConcept C2910587157 @default.
• W1703283460 hasConcept C535046627 @default.
• W1703283460 hasConcept C558461103 @default.
• W1703283460 hasConcept C71924100 @default.
• W1703283460 hasConceptScore W1703283460C118552586 @default.
• W1703283460 hasConceptScore W1703283460C126322002 @default.
• W1703283460 hasConceptScore W1703283460C12770488 @default.
• W1703283460 hasConceptScore W1703283460C159110408 @default.
• W1703283460 hasConceptScore W1703283460C16568411 @default.
• W1703283460 hasConceptScore W1703283460C1862650 @default.
• W1703283460 hasConceptScore W1703283460C197934379 @default.
• W1703283460 hasConceptScore W1703283460C203092338 @default.
• W1703283460 hasConceptScore W1703283460C2778375690 @default.
• W1703283460 hasConceptScore W1703283460C2778541695 @default.
• W1703283460 hasConceptScore W1703283460C2779951463 @default.
• W1703283460 hasConceptScore W1703283460C2910587157 @default.
• W1703283460 hasConceptScore W1703283460C535046627 @default.
• W1703283460 hasConceptScore W1703283460C558461103 @default.
• W1703283460 hasConceptScore W1703283460C71924100 @default.

• next